Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anesthetic Methods and Gut Microbiota/Metabolomics Following Hepatectomy
NCT04767503Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Feb 2021
- Primary completion
- Sep 2022
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Trial of propofol and desflurane in hepatic tumor (2 arms), sponsored by National Taiwan University Hospital. Primary endpoints: Microbiota analysis at 1 month and Metabolomics at 1 month. Started Feb 2021; status: completed.
02
Drugs
propofoldesflurane
03
Conditions
hepatic tumor
Beyond the preview
Go deeper on NCT04767503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04767503.